Pittsburgh researchers engineer and successfully test SARS corona vaccine in animal model

December 04, 2003

PITTSBURGH, Dec. 4 -- Research by scientists at the University of Pittsburgh School of Medicine and the Graduate School of Public Health (GSPH) in collaboration with colleagues at the Centers for Disease Control and Prevention (CDC) in Atlanta has shown that an adenoviral-based vaccine can induce SARS-coronavirus (SARS-CoV)-specific T-cell and virus-neutralizing antibody responses.

The study, which represents the first published work on the development of a SARS vaccine and comes only a few months after the SARS coronavirus was identified and its genome was sequenced, is reported in a fast track research letter in the Dec. 6 issue of The Lancet.

"It is our hope that this research will lead to a protective vaccine against SARS," stated project leader Andrea Gambotto, M.D., from the departments of surgery and medicine, division of infectious diseases and the Molecular Medicine Institute (MMI) at the University of Pittsburgh School of Medicine.

In the study, researchers immunized six rhesus macaques intramuscularly with a combination of three SARS-CoV vectors. Two additional macaques were immunized with the same amount of empty adenoviral vector and served as controls. After 28 days, the animals received a second vaccination. Six weeks after vaccination, T-cells and antibodies against SARS were detected in all six of the immunized animals, but not in either of the control animals. The intensity of the response varied among animals but was generally largest after the booster vaccination, according to the Pittsburgh researchers. Serum samples from the vaccinated animals, but not from the controls, showed strong neutralizing capacity against SARS-CoV.

"From a scientific perspective, several points are important. We obtained the recombinant vaccine by engineering a common cold virus to express the SARS coronavirus antigens. This is a successful strategy that we are exploring for other infectious diseases such as HIV," said Dr. Gambotto. "After injection, the vaccine acts as a Trojan Horse, first by infecting cells in the body, and then stimulating an immune reaction to the delivered SARS antigens, ultimately conferring protection against the disease. Also, the induced immune reaction appears to be broad: both antibody and cell-mediated immune responses, equally important for protection from viral infections, were detected in the test animals," he said.

Dr. Gambotto went on to say that the researchers will now test the vaccine in ferrets, which have been shown by a group of Dutch researchers to develop SARS symptoms after SARS-coronavirus infection, unlike the monkeys in the current vaccine study.

"This testing is important to fully assess the ability of our recombinant vaccine to protect from subsequent exposure to the SARS coronavirus. We also are soon planning human clinical trials in the near future here at the University of Pittsburgh as part of the MMI initiative," Dr. Gambotto said. The MMI is the nucleus for gene and protein therapy research at the University of Pittsburgh and provides the infrastructure and resources necessary to rapidly translate gene therapy protocols from bench to bedside.

SARS emerged as a threatening and deadly infectious disease last year in China. For Wentao Gao, M.D., Ph.D., research instructor in the department of surgery and co-author of the study, his participation in this research was especially meaningful because SARS claimed several lives in his hometown of Changchun, Jilin. "I am proud of what I have contributed in the development of a SARS vaccine, given that the adenoviral-based vaccine is economical and suitable for a large population. I hope we will soon be able to translate this vaccine into clinical trials to test its toxicity and efficacy," he said.

Other University of Pittsburgh researchers who participated in this study include Leonardo D'Aiuto, Ph.D., and Edward Nwanegbo, M.D., post-doctoral fellows in the department of surgery who work in Dr. Gambotto's lab; Paul D. Robbins, Ph.D., professor of molecular genetics and biochemistry; Simon Barratt-Boyes, Ph.D., assistant professor in the department of infectious disease and microbiology at the University of Pittsburgh Graduate School of Public Health; and Adam Soloff, B.S., a GSPH student who works in Dr. Barratt-Boyes' lab. Additional collaborators are William J. Bellini, Ph.D., and Azaibi Tamin, Ph.D., from the National Center for Infectious Diseases, at the CDC in Atlanta.
-end-
The study was funded by a grant from the National Heart, Lung and Blood Institute's Program of Excellence in Gene Therapy. The University of Pittsburgh is one of five centers nationwide that participate in this program.

CONTACT:
Frank Raczkiewicz
Jocelyn Uhl
PHONE: 412-647-3555
FAX: 412-624-3184
E-MAIL:
RaczkiewiczFA@upmc.edu
UhlJH@upmc.edu

University of Pittsburgh Medical Center

Related Public Health Articles from Brightsurf:

COVID-19 and the decolonization of Indigenous public health
Indigenous self-determination, leadership and knowledge have helped protect Indigenous communities in Canada during the coronavirus disease 2019 (COVID-19) pandemic, and these principles should be incorporated into public health in future, argue the authors of a commentary in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.200852.

Public health consequences of policing homelessness
In a new study examining homelessness, researchers find that policy such a lifestyle has massive public health implications, making sleeping on the street even MORE unhealthy.

Electronic health information exchange improves public health disease reporting
Disease tracking is an important area of focus for health departments in the midst of the COVID-19 pandemic.

Pandemic likely to cause long-term health problems, Yale School of Public Health finds
The coronavirus pandemic's life-altering effects are likely to result in lasting physical and mental health consequences for many people--particularly those from vulnerable populations--a new study led by the Yale School of Public Health finds.

The Lancet Public Health: US modelling study estimates impact of school closures for COVID-19 on US health-care workforce and associated mortality
US policymakers considering physical distancing measures to slow the spread of COVID-19 face a difficult trade-off between closing schools to reduce transmission and new cases, and potential health-care worker absenteeism due to additional childcare needs that could ultimately increase mortality from COVID-19, according to new modelling research published in The Lancet Public Health journal.

The Lancet Public Health: Access to identification documents reflecting gender identity may improve trans mental health
Results from a survey of over 20,000 American trans adults suggest that having access to identification documents which reflect their identified gender helps to improve their mental health and may reduce suicidal thoughts, according to a study published in The Lancet Public Health journal.

The Lancet Public Health: Study estimates mental health impact of welfare reform, Universal Credit, in Great Britain
The 2013 Universal Credit welfare reform appears to have led to an increase in the prevalence of psychological distress among unemployed recipients, according to a nationally representative study following more than 52,000 working-age individuals from England, Wales, and Scotland over nine years between 2009-2018, published as part of an issue of The Lancet Public Health journal on income and health.

BU researchers: Pornography is not a 'public health crisis'
Researchers from the Boston University School of Public Health (BUSPH) have written an editorial in the American Journal of Public Health special February issue arguing against the claim that pornography is a public health crisis, and explaining why such a claim actually endangers the health of the public.

The Lancet Public Health: Ageism linked to poorer health in older people in England
Ageism may be linked with poorer health in older people in England, according to an observational study of over 7,500 people aged over 50 published in The Lancet Public Health journal.

Study: Public transportation use linked to better public health
Promoting robust public transportation systems may come with a bonus for public health -- lower obesity rates.

Read More: Public Health News and Public Health Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.